– CLSA on Insurance:
– Notable change in regulator’s draft guideline focuses on surrender value calculation for non-linked savings policies.
– New method likely to result in surrender values 10%-2x higher, potentially impacting insurers.
– Jefferies on Insurance:
– IRDAI proposes lower surrender charges on non-ulips.
– Introduction of threshold premium concept may increase surrender values, reducing fees for insurers.
– Final terms pending deliberations, insurers may offset impact by lowering costs.
– Nomura on IRDAI Proposal:
– Anticipates higher surrender values and lower VNB margins for non-linked insurance products.
– Concerns about potential deterrence of long-term investing by policyholders.
– Implementation could affect IRR on non-linked insurance products, with significant implications for product design and pricing.
– MS on Insurance:
– IRDA proposes higher surrender value on non-linked products.
– Investor concerns on VNB margins may be mitigated with industry options.
– HSBC on Real Estate (2024 outlook):
– Buy recommendations for Sobha and Prestige, hold for DLF and GPL, reduce for Oberoi.
– Target price adjustments based on outlook for each.
– HSBC on Consumer (2024 outlook):
– Predicts a deepening divergence in valuation and earnings growth in 2023.
– Emphasizes pricing power as key, expecting staples to underperform discretionary.
– Key ideas for 2024 include Avenue Supermarts, Asian Paints, Colgate (upgraded to Buy), Titan, and Nykaa.
– MS on Bharti Airtel:
– Assumes a cumulative ARPU increase of >20% over the next 24-30 months.
– Believes this increase is already reflected in the current stock price.
– UBS on Dixon Tech:
– Initiates Buy with a target price of Rs 7700.
– Highlights diversification and substantial opportunities in mobile and IT hardware.
– Acknowledges the higher valuation, justified by strong earnings CAGR.
– UBS on Amber Ent:
– Initiates Buy with a target price of Rs 4075.
– Points to a pivot to components and electronics adding drivers and sustainability.
– Identifies key risks, including customer concentration, labor relations, commodity price volatility, and competition.
– UBS on BEL:
– Recommends Buy with a target price of Rs 205.
– Expects order intake to be revised up, benefiting from the expanding defense manufacturing ecosystem.
Bringing you the latest updates on finance, economies, stocks, bonds, and more. Stay informed with timely insights.
Be First to Comment